Search research articles
Contact Us
Filters
Showing results (21-30 of 29) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 29 results.
Nature Immunology
|
September 17, 2024
Epigenetic tuning of PD-1 expression improves exhausted T cell function and viral control
Sarah A Weiss, Amy Y Huang, Megan E Fung, et al.
Nature Immunology
|
July 27, 2021
Differentiation of exhausted CD8<sup>+</sup> T cells after termination of chronic antigen stimulation stops short of achieving functional T cell memory
Pierre Tonnerre, David Wolski, Sonu Subudhi, et al.
Nature
|
December 19, 2018
Loss of ADAR1 in tumours overcomes resistance to immune checkpoint blockade
Jeffrey J Ishizuka, Robert T Manguso, Collins K Cheruiyot, et al.
Cancer Immunology Research
|
September 21, 2021
Supporting the Next Generation of Scientists to Lead Cancer Immunology Research
Elise Alspach, Ryan D Chow, Shadmehr Demehri, et al.
Biorxiv : the Preprint Server for Biology
|
December 3, 2025
Lymphotoxin-driven cancer cell eradication by tumoricidal CD8<sup>+</sup> TIL
Hongyan Xie, Aiping Jiang, Aonkon Dey, et al.
Biorxiv : the Preprint Server for Biology
|
February 26, 2024
Disrupting CD38-driven T cell dysfunction restores sensitivity to cancer immunotherapy
Or-Yam Revach, Angelina M Cicerchia, Ofir Shorer, et al.
Cell Reports. Medicine
|
June 27, 2025
Overcoming resistance to immunotherapy by targeting CD38 in human tumor explants
Or-Yam Revach, Angelina M Cicerchia, Ofir Shorer, et al.
Nature
|
January 12, 2023
Targeting TBK1 to overcome resistance to cancer immunotherapy
Yi Sun, Or-Yam Revach, Seth Anderson, et al.
Nature
|
October 4, 2023
The PTPN2/PTPN1 inhibitor ABBV-CLS-484 unleashes potent anti-tumour immunity
Christina K Baumgartner, Hakimeh Ebrahimi-Nik, Arvin Iracheta-Vellve, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 29) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 29 results.
Nature Immunology
|
September 17, 2024
Epigenetic tuning of PD-1 expression improves exhausted T cell function and viral control
Sarah A Weiss, Amy Y Huang, Megan E Fung, et al.
Nature Immunology
|
July 27, 2021
Differentiation of exhausted CD8<sup>+</sup> T cells after termination of chronic antigen stimulation stops short of achieving functional T cell memory
Pierre Tonnerre, David Wolski, Sonu Subudhi, et al.
Nature
|
December 19, 2018
Loss of ADAR1 in tumours overcomes resistance to immune checkpoint blockade
Jeffrey J Ishizuka, Robert T Manguso, Collins K Cheruiyot, et al.
Cancer Immunology Research
|
September 21, 2021
Supporting the Next Generation of Scientists to Lead Cancer Immunology Research
Elise Alspach, Ryan D Chow, Shadmehr Demehri, et al.
Biorxiv : the Preprint Server for Biology
|
December 3, 2025
Lymphotoxin-driven cancer cell eradication by tumoricidal CD8<sup>+</sup> TIL
Hongyan Xie, Aiping Jiang, Aonkon Dey, et al.
Biorxiv : the Preprint Server for Biology
|
February 26, 2024
Disrupting CD38-driven T cell dysfunction restores sensitivity to cancer immunotherapy
Or-Yam Revach, Angelina M Cicerchia, Ofir Shorer, et al.
Cell Reports. Medicine
|
June 27, 2025
Overcoming resistance to immunotherapy by targeting CD38 in human tumor explants
Or-Yam Revach, Angelina M Cicerchia, Ofir Shorer, et al.
Nature
|
January 12, 2023
Targeting TBK1 to overcome resistance to cancer immunotherapy
Yi Sun, Or-Yam Revach, Seth Anderson, et al.
Nature
|
October 4, 2023
The PTPN2/PTPN1 inhibitor ABBV-CLS-484 unleashes potent anti-tumour immunity
Christina K Baumgartner, Hakimeh Ebrahimi-Nik, Arvin Iracheta-Vellve, et al.
Page
of 3